Stock RO ROCHE HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Company Roche Holding AG Berne S.E.

Equities

RO

CH0012032113

Pharmaceuticals

Real-time Estimate Cboe Europe
Other stock markets
 03:06:57 06/06/2024 pm IST 		5-day change 1st Jan Change
265.2 CHF +11.72% Intraday chart for Roche Holding AG -0.47% -8.62%
05/06 The odds of rates getting cut in 2024 may be better than you think Our Logo
03/06 ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating ZD

Business Summary

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Sales per Business

CHF in Million2022Weight2023Weight Delta
Pharmaceuticals
76.6 %
48,628 73.2 % 46,279 76.6 % -4.83%
Diagnostics
23.4 %
17,798 26.8 % 14,162 23.4 % -20.43%

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
46.9 %
29,313 44.1 % 28,352 46.9 % -3.28%
Rest of Europe
16.1 %
10,328 15.5 % 9,703 16.1 % -6.05%
Rest of Asia
14.7 %
9,852 14.8 % 8,890 14.7 % -9.76%
Japan
7.4 %
6,452 9.7 % 4,464 7.4 % -30.81%
Latin America
4.9 %
2,870 4.3 % 2,971 4.9 % +3.52%
Germany
4.8 %
3,318 5.0 % 2,893 4.8 % -12.81%
Africa, Australia and Oceania
2.0 %
1,520 2.3 % 1,212 2.0 % -20.26%
Switzerland
1.8 %
1,671 2.5 % 1,118 1.8 % -33.09%
Rest of North America
1.4 %
1,102 1.7 % 838 1.4 % -23.96%

Managers

Managers TitleAgeSince
Thomas Schinecker CEO
 Chief Executive Officer 49 01/03/01
Severin Schwan CHM
 Chairman 57 01/08/01
Alan Hippe DFI
 Director of Finance/CFO 57 01/11/01
Pascale Schmidt CMP
 Compliance Officer 51 01/20/01
Levi Garraway CTO
 Chief Tech/Sci/R&D Officer - -
Bruno Eschli IRC
 Investor Relations Contact - -
Silke Hörnstein PRN
 Corporate Officer/Principal 49 01/15/01
Annette Luther SEC
 Corporate Secretary 54 01/20/01
Claudia Boeckstiegel LAW
 General Counsel 60 01/20/01
Cristina A. Wilbur HRO
 Human Resources Officer 57 -

Members of the board

Members of the board TitleAgeSince
Bernard Poussot BRD
 Director/Board Member 72 03/15/03
Ulf Mark Schneider BRD
 Director/Board Member 59 -
André S. Hoffmann BRD
 Director/Board Member 66 01/96/01
Patrick Frost BRD
 Director/Board Member 56 17/20/17
Hans Clevers PRN
 Corporate Officer/Principal 67 05/19/05
Severin Schwan CHM
 Chairman 57 01/08/01
Anita Hauser BRD
 Director/Board Member 55 14/17/14
Richard P. Lifton BRD
 Director/Board Member 71 03/15/03
Claudia Dyckerhoff BRD
 Director/Board Member 58 01/16/01
Joerg Duschmale BRD
 Director/Board Member 40 17/20/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 106,691,000 28,989,189 ( 27.17 %) 0 88.91 %
Stock B 1 702,562,700 690,549,674 ( 98.29 %) 12,011,755 ( 1.710 %)

Shareholders

NameEquities%Valuation
ROCHE HOLDING AG
1.434 %
10,073,029 1.434 % 2 423 M CHF
MFS International (UK) Ltd.
0.5802 %
4,075,977 0.5802 % 980 M CHF
Amundi Asset Management SA (Investment Management)
0.4645 %
3,263,726 0.4645 % 785 M CHF
March Asset Management SGIIC SAU
0.2745 %
1,928,551 0.2745 % 464 M CHF
MFS International Singapore Pte Ltd.
0.2283 %
1,604,065 0.2283 % 386 M CHF
State Street Global Advisors Ltd.
0.2203 %
1,548,024 0.2203 % 372 M CHF
Nordea Investment Management AB
0.1425 %
1,001,324 0.1425 % 241 M CHF
Sjunde AP-fonden
0.1398 %
982,359 0.1398 % 236 M CHF
Barings (UK) Ltd.
0.1228 %
862,766 0.1228 % 208 M CHF
CAPFI DELEN Asset Management NV
0.1206 %
847,365 0.1206 % 204 M CHF
NameEquities%Valuation
Saratoga Research & Investment Management
0.0437 %
2,458,918 0.0437 % 78 M CHF
Pacer Advisors, Inc.
0.0200 %
1,124,954 0.0200 % 36 M CHF
Aristotle Capital Management LLC
0.009284 %
521,790 0.009284 % 17 M CHF
MFS International (UK) Ltd.
0.008446 %
474,717 0.008446 % 15 M CHF
Boston Common Asset Management LLC
0.008147 %
457,875 0.008147 % 15 M CHF
Old National Bank (Investment Management)
0.004574 %
257,096 0.004574 % 8 M CHF
Hikari Power Ltd.
0.004231 %
237,820 0.004231 % 8 M CHF
Kornitzer Capital Management, Inc.
0.004052 %
227,748 0.004052 % 7 M CHF
Altrius Capital Management, Inc.
0.003775 %
212,158 0.003775 % 7 M CHF
Meritage Portfolio Management, Inc.
0.003109 %
174,714 0.003109 % 6 M CHF
NameEquities%Valuation
Hoffmann Family
64.97 %
69,318,000 64.97 % 18 200 M CHF
Maja Oeri
7.584 %
8,091,900 7.584 % 2 125 M CHF
Severin Schwan
0.2294 %
244,786 0.2294 % 64 M CHF
zCapital AG
0.1087 %
116,000 0.1087 % 30 M CHF
ODDO BHF Trust GmbH
0.0930 %
99,200 0.0930 % 26 M CHF
State Street Global Advisors Ltd.
0.0632 %
67,460 0.0632 % 18 M CHF
Goldman Sachs Asset Management International
0.0399 %
42,534 0.0399 % 11 M CHF
Amundi Asset Management SA (Investment Management)
0.0367 %
39,161 0.0367 % 10 M CHF
Sjunde AP-fonden
0.0352 %
37,557 0.0352 % 10 M CHF
KLP Kapitalforvaltning AS
0.0309 %
32,940 0.0309 % 9 M CHF

Holdings

NameEquities%Valuation
CHUGAI PHARMACEUTICAL CO., LTD
59.89%
 1,005,670,000 59.89% 32,272,955,970 $
ROCHE HOLDING AG
1.43%
 10,073,029 1.43% 2,422,842,800 $
ENTRADA THERAPEUTICS, INC.
8.15%
 2,744,120 8.15% 33,917,323 $
JASPER THERAPEUTICS, INC.
3.02%
 454,961 3.02% 9,636,074 $
ALIGOS THERAPEUTICS, INC.
15.19%
 11,025,941 15.19% 9,019,220 $
ELOXX PHARMACEUTICALS, INC.
0.06%
 1,893 0.06% 1,486 $

Company contact information

Roche Holding AG

Grenzacherstrasse 124

4058, Basel

+41 61 688 11 11

http://www.roche.com
address Roche Holding AG(RO)

Group companies

NameCategory and Sector
Viewics India Pvt Ltd.
Roche Finance Europe BV
Finance/Rental/Leasing
Roche Financial Management Ltd.
Roche Catalyst Investments Ltd.
Roche Financial Investments Ltd.
Roche Intertrade Ltd.
Roche Pharmholding BV
Logo Roche Pharmholding BV

Roche Pharmholding BV

Medical DistributorsDistribution Services

Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands.

Medical Distributors
Roche Diagnostics India Pvt Ltd.
Logo Roche Diagnostics India Pvt Ltd.

Roche Diagnostics India Pvt Ltd.

Medical SpecialtiesHealth Technology

Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers.

Medical Specialties
Roche Diagnostics Belgium NV
Logo Roche Diagnostics Belgium NV

Roche Diagnostics Belgium NV

BiotechnologyHealth Technology

Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker.

Biotechnology

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
236.1 CHF
Average target price
277.5 CHF
Spread / Average Target
+17.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.69% 75TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.48% 61TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.87% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.74% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+6.76% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.66% 25TCr
NOVARTIS AG Stock Novartis AG
+11.18% 22TCr
PFIZER, INC. Stock Pfizer, Inc.
+2.64% 17TCr
AMGEN INC. Stock Amgen Inc.
+6.72% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ROG Stock
  4. RO Stock
  5. Company Roche Holding AG